Stoke Therapeutics, Inc. (STOK)

NASDAQ: STOK · Real-Time Price · USD

30.87

-0.18 (-0.58%)

At close: Dec 5, 2025, 4:00 PM EST

31.04

+0.17 (0.55%)

After-hours: Dec 5, 2025, 5:13 PM EST

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Antisense Oligonucleotide	8.78M	Log In
Antisense Oligonucleotide Growth	-29.22%	Log In

Revenue by Geography

Fiscal year is January - December.